Pharma
Survey of 150 labs reveals how parallel systems drive shadow AI adoption and create operational inefficiencies
Updated | 1 min read
Pricing reforms, tariffs, and domestic manufacturing incentives are redefining where life sciences labs operate
| 2 min read
US–UK pricing commitments, tariff changes, and investment expectations could influence lab budgets and supply chains
| 2 min read
Choose the right partner with the right functionality for today, with room to grow with you for tomorrow
| 4 min read
Start your AI journey in your lab by ensuring AI-ready data and creating a technology framework that supports advanced analytics
| 5 min read
Investments in domestic pharmaceutical manufacturing are reshaping laboratory strategies, from automation and AI to workforce development and compliance
| 5 min read
Learn how lab managers navigate challenges in gene therapy development while optimizing efficiency and ensuring safety for new treatments
| 4 min read
Validated methods and technologies help labs meet regulatory expectations and address technical challenges in PFAS analysis and beyond
| 1 min read
